ESTRO 38 - Programme Book & Exhibition Guide
Astrazeneca Sunday 28 April 2019 | 13:15-14:15 | Brown 3
SUNDAY 28 APRIL 2019
Chemoradiation Followed by Immunotherapy: Transforming the Approach for Treating Unresectable Stage III NSCLC Speakers: Roy Decker, MD, PhD, Radiation Oncologist, Yale Cancer Center, USA Francesco Grossi, MD, Medical Oncologist, Fondazione IRCCS Ca’ Granda Policlinico di Milano, Italy
Shankar Siva, MD, PhD, Radiation Oncologist, Peter MacCallum Cancer Centre, Australia
> Immunotherapy Overview and Importance of Multidisciplinary Care in Stage III NSCLC Faculty: Shankar Siva, MD, PhD, Peter MacCallum Cancer Centre, Australia Treatment for Unresectable Stage III NSCLC: Approaches and Management of CRT Faculty: Roy Decker, MD, PhD, Yale Cancer Center, United States Treatment for Unresectable Stage III NSCLC: Immunotherapy After CRT Faculty: Francesco Grossi, MD, Fondazione IRCCS, Ca’ Granda Policlinico, di Milano, Italy
13:15-13:25
13:25-13:40 >
13:40-14:00 >
Question and Answer session Panel
14:00-14:10 >
Summary and Closing Remarks Faculty: Shankar Siva, MD, PhD, Peter MacCallum Cancer Centre, Australia
14:10-14:15
>
Visit Astrazeneca, booth 5800 for more information
SATELLITE SYMPOSIA | Programme and Exhibition Guide
386
Made with FlippingBook Annual report